Craig Mitchell Zaidman MD
Assistant Professor, Neurology, Washington University School of Medicine
Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-362-3752
Dr. Zaidman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Clinical Neurophysiology, 2007 - 2008- Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 2005 - 2007
Rhode Island Hospital/Brown University HealthResidency, Neurology, 2003 - 2004- Brown UniversityResidency, Pediatrics, 2001 - 2003
University of Virginia School of MedicineClass of 2001
Certifications & Licensure
IL State Medical License 2021 - 2029
MO State Medical License 2007 - 2027
RI State Medical License 2003 - 2006
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- Spinraza in Adult Spinal Muscular Atrophy Start of enrollment: 2018 Aug 16
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) Start of enrollment: 2018 Sep 25
Publications & Presentations
PubMed
- Biallelic SCO2 Variants Presenting as Motor-Predominant Axonal Neuropathy With Complex IV Deficiency.Adriana P Rebelo, Katie Lutz, Tiffany Grider, Craig M Zaidman, Michael E Shy
Journal of the Peripheral Nervous System. 2026-09-01 - Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.Aravindhan Veerapandiyan, John Bourke, Jonathan H Soslow, John W Day, Craig M McDonald
Cardiology and Therapy. 2026-07-01 - 1 citationsA prospective, multi-center, observational study of the safety, tolerability and effectiveness of Nusinersen in adult patients with spinal muscular atrophy.Craig M Zaidman, Crystal Proud, Bing Liao, Nassim Rad, Doreen Ho
Neuromuscular Disorders. 2026-05-01
Journal Articles
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingPaula R Clemens, Vamshi K Rao, Craig M Zaidman, JAMA Neurology
- CANOMAD and Other Chronic Ataxic Neuropathies with Disialosyl Antibodies (CANDA)R Brian Sommerville, Craig M Zaidman, Glenn Lopate, Alan Pestronk, Conrad C Weihl, Robert C Bucelli, Journal of Neurology
Authored Content
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 2020
Press Mentions
Washington University Researchers to Present Findings at National Neurology MeetingOctober 3rd, 2019- Duchenne Muscular Dystrophy Gene TherapyJuly 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
